CEBP Meeting Calendar Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Epidemiology Biomarkers & Prevention 16, 634, March 1, 2007. doi: 10.1158/1055-9965.EPI-07-0078
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Albrektsen, G.
Right arrow Articles by Kvåle, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Albrektsen, G.
Right arrow Articles by Kvåle, G.
Related Collections
Right arrowRelated Article

Letter

Pregnancy Levels of Estrogen and Progesterone: The Double-Edged Sword

Grethe Albrektsen and Ivar Heuch

Department of Mathematics, University of Bergen, Norway

Steinar Thoresen

Cancer Registry of Norway, Oslo, Norway

Gunnar Kvåle

Center for International Health, University of Bergen, Norway

In Response: As Dr. Ferretti et al. emphasize, it is essential to distinguish between short-term and long-term effects of pregnancies on the risk of breast cancer. A main result from our study on association between clinical stage of breast cancer and time since last full-term birth (1) was that the proportion of breast cancer patients presenting with advanced disease, among women diagnosed 2 to 6 years after birth, was similar to, or even higher than, the proportion among women diagnosed during pregnancy or within 2 years after birth. This pattern, however, was seen only in certain categories defined by parity and maternal age at delivery, apparently coinciding with subgroups and time periods with the most pronounced postpartum transient increase in risk of breast cancer (2). This finding indicates that pregnancy-related factors may have a progressive effect on breast cancer tumors, in addition to a potential promoting effect.

Pregnancy estrogens have been hypothesized to have a growth-enhancing effect on premalignant breast cells (3). However, pregnancy-related breast cancer tumors are often estrogen-receptor negative. A direct effect of estrogens is thus less likely, and this led us to speculate that other pregnancy hormones, possibly prolactin, may be of importance (1). As discussed in our paper (1), prolactin levels have been found to increase with increasing maternal age, and experimental research has shown a promoting as well as progressive effect of prolactin. As Ferretti et al. point out, however, other mechanisms have also been suggested.

Ferretti et al. outline the next logical step that could bring us to a better understanding of pregnancy-related breast cancer. Actually, an initial step has already been taken. We are now in the planning phase of a collaboration work with Dr. Pepper Schedin to explore the involution-inflammation hypothesis (4, 5). An interaction between inflammation and endogenous hormones is also possible (6). Results from our study may provide new knowledge that can be used in prevention and treatment of pregnancy-related breast cancer.


    References
 Top
 References
 

  1. Albrektsen G, Heuch I, Thoresen S, Kvåle G. Clinical stage of breast cancer by parity, age at birth, and time since birth: a progressive effect of pregnancy hormones?. Cancer Epidemiol Biomarkers Prev 2006;15:65–9.[Abstract/Free Full Text]
  2. Albrektsen G, Heuch I, Hansen S, Kvåle G. Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer 2005;92:167–75.[CrossRef][Medline]
  3. Henderson BE, Bernstein L. The international variation in breast cancer rates: an epidemiological assessment. Breast Cancer Res Treat 1991;18:S11–7.[CrossRef][Medline]
  4. McDaniel SM, Rumer KK, Biroc SL, et al. Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis. Am J Pathol 2006;168:608–20.[Abstract/Free Full Text]
  5. Schedin P. Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 2006;6:281–91.[CrossRef][Medline]
  6. Ness RB, Modugno F. Endometriosis as a model for inflammation-hormone interactions in ovarian and breast cancers. Eur J Cancer 2006;42:691–703.[CrossRef][Medline]

Related Article

Pregnancy Levels of Estrogen and Progesterone: The Double-Edged Sword
Gianluigi Ferretti, Alessandra Felici, and Francesco Cognetti
Cancer Epidemiol. Biomarkers Prev. 2007 16: 634. [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Albrektsen, G.
Right arrow Articles by Kvåle, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Albrektsen, G.
Right arrow Articles by Kvåle, G.
Related Collections
Right arrowRelated Article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online